MedPath

COVID-19 Self-testing IMPROVE

Not Applicable
Completed
Conditions
COVID-19
Registration Number
NCT06576167
Lead Sponsor
Temple University
Brief Summary

The study aims to engage community partners to implement IMPROVE intervention and promote (COVID-19) rapid testing among vulnerable Asian Americans in the Greater Philadelphia Area and New York City

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1271
Inclusion Criteria
  • (1) self-identified as Asian from one of the subgroups: Chinese, Korean, Vietnamese, Filipino, or other South Asian Americans,
  • (2) aged 18 and above,
  • (3) living in the Greater Philadelphia or NYC areas,
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
the change in the rate of COVID-19 self-testingbaseline, 1-month follow up, and 3-month follow up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Asian Health, Lewis Katz School of Medicine, Temple University

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Center for Asian Health, Lewis Katz School of Medicine, Temple University
πŸ‡ΊπŸ‡ΈPhiladelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.